GDNA News and Press, Goldman Sachs Human Evolution ETF From 10/15/19

A preliminary analysis from the nonpartisan Congressional Budget Office (CBO) found that House Speaker Nancy Pelosi's (D-CA 12th District) bill to lower drug prices would save Medicare $345B between 2023 and 2029 by allowing the Secretary of Health and Human Services to negotiated lower pr...

By Ansh Chaudhary The ETF Deathwatch list increased in September. Twenty-five exchange-traded products ("ETPs") were added to the list and 12 funds were removed. Of the removals, 10 were removed due to increased health and two were due to asset managers closing their funds. September was a...

According to a new report from the nonprofit Institute for Clinical and Economic Review (ICER), AbbVie ( ABBV -0.6% ) and Roche ( OTCQX:RHHBY -1.6% ) were number one and two, respectively, in terms of the impact of their price increases on U.S. drug spending. More news on: AbbVie Inc...